Curcumin mediates glutathione depletion via metal–organic framework nanocarriers to enhance cisplatin chemosensitivity on esophageal cancer
Abstract Cisplatin (CDDP) is the primary drug used in the initial treatment of esophageal cancer (EC). However, its side effects and resistance can limit its effectiveness in clinical therapy. Curcumin (Cur)-mediated glutathione (GSH) depletion can reverse resistance, enhance the chemosensitivity of...
        Saved in:
      
    
          | Main Authors: | , , , , , , , | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Springer
    
        2024-12-01 | 
| Series: | Discover Nano | 
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s11671-024-04168-5 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
 
       